🇺🇸 FDA
Patent

US 12269872

Neutralizing antibodies to Plasmodium falciparum circumsporozoite protein and their use

granted A61KA61K2039/505A61K2039/55572

Quick answer

US patent 12269872 (Neutralizing antibodies to Plasmodium falciparum circumsporozoite protein and their use) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Apr 03 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Apr 08 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 03 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
31
CPC classes
A61K, A61K2039/505, A61K2039/55572, A61K2039/55577, A61K39/015